These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16212125)

  • 21. Anti-tuberculosis drug resistance pattern among pulmonary tuberculosis patients with or without HIV infection in Mwanza, Tanzania.
    Range N; Friis H; Mfaume S; Magnussen P; Chanualucha J; Kilale A; Mugomela A; Andersen AB
    Tanzan J Health Res; 2012 Oct; 14(4):243-9. PubMed ID: 26591721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis.
    Thai PVK; Ha DTM; Hanh NT; Day J; Dunstan S; Nhu NTQ; Kiet VS; Lan NH; Dung NH; Lan NTN; Thuong NT; Lan NN; Liễu PTT; Hồng NT; Điệp ĐC; Thanh NTK; Hội NV; Nghĩa NV; Đại TN; Minh HQ; Thơm NV; Farrar J; Caws M
    BMC Infect Dis; 2018 Mar; 18(1):112. PubMed ID: 29510687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug resistance pattern in Mycobacterium tuberculosis to the first line drugs of pulmonary tuberculosis patients at Hazara Region, Pakistan.
    Jan F; Wali S; Sadia S; Akbar MT; Akbar HS; Ahmad W; Ahmad M; Khalid A
    Tuberk Toraks; 2018 Mar; 66(1):26-31. PubMed ID: 30020038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
    Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
    JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
    Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
    BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
    Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-tuberculosis drug resistance in Ethiopia: systematic review.
    Weldegebreal S; Mebrahtu T
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):18-22. PubMed ID: 28157460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
    Tembo BP; Malangu NG
    BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
    Lukoye D; Ssengooba W; Musisi K; Kasule GW; Cobelens FG; Joloba M; Gomez GB
    BMC Public Health; 2015 Mar; 15():291. PubMed ID: 25880829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.
    Goswami A; Chakraborty U; Mahapatra T; Mahapatra S; Mukherjee T; Das S; Das A; Dey SK; Ray S; Bhattacharya B; Pal NK
    PLoS One; 2014; 9(10):e109563. PubMed ID: 25289974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance in pulmonary tuberculosis in new and previously treated cases: experience from Turkey.
    Komurcuoglu B; Senol G; Balci G; Yalnız E; Ozden E
    J Infect Public Health; 2013 Aug; 6(4):276-82. PubMed ID: 23806702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Drug Resistance Pattern of
    Mohammed KAS; Khudhair GS; Al-Rabeai DB
    Pol J Microbiol; 2022 May; 71(2):205-215. PubMed ID: 35675816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
    Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
    J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.